TARRYTOWN, New York, April 23, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica Inc. (PXMD) (the “Company”), a leading biopharmaceutical company dedicated to advancing treatments for neurological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results